O-(2-hydroxyethyl)resorcinol | 49650-88-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: O-(2-hydroxyethyl)resorcinol
• 英文别名: 3-(2-Hydroxyethoxy)phenol；2-(3-hydroxyphenoxy)ethanol；O-2-hydroxyethyl resorcinol；O-Hydroxyethylresorcinol；2-(3-hydroxy-phenoxy)-ethanol
• CAS: 49650-88-6
• 化学式: C₈H₁₀O₃
• 分子量: 154.166
• InChiKey: KKOWMCYVIXBCGE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  49.7
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  O-(2-hydroxyethyl)resorcinol 在 4-二甲氨基吡啶 、 18-冠醚-6 、 potassium carbonate 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 potassium iodide 作用下， 以 二氯甲烷 、 丙酮 为溶剂， 反应 312.0h， 生成 benzylviologen-rhodamine B dyad
  参考文献：
  名称：

  Fluorescence-On Response via CB7 Binding to Viologen–Dye Pseudorotaxanes

  摘要：

  Fluorescence-on sensors typically rely on disrupting photoinduced electron transfer quenching of the excited state through binding the electron donor. To provide a more general fluorescence-on signaling unit, a quencher-fluorophore dyad has been developed in which quenching by electron transfer to a tethered viologen acceptor can be disrupted through complexation of the viologen by cucurbit[7]uril (CB7). Dyads of benzyl viologen-rhodamine B or a BODIPY fluorophore gave upon CB7 complexation 14- and 30-fold fluorescence enhancement, respectively.

  DOI：

  10.1021/ol300963c
• 作为产物：
  描述：

  ethyl [3-(acetyloxy)phenoxy]acetate 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 以100%的产率得到O-(2-hydroxyethyl)resorcinol
  参考文献：
  名称：

  PYRROLE DERIVATIVE

  摘要：

  公开号：

  EP1386913B1

文献信息

• Aryl and aryloxyalkyl sulfamate esters useful as anticonvulsants
  申请人：A. H. Robins Co., Inc.

  公开号：US05025031A1

  公开（公告）日：1991-06-18

  Herein disclosed is a method of treating convulsions with a pharmaceutical composition containing a compound of the formula: (HO).sub.p --A--[OSO.sub.2 NR.sup.1 R.sup.2 ].sub.z where A is an aryl, arylalkyl, or aryloxyalkyl group and is substituted on 1 or more carbon atoms with a sulfamate group (--OSO.sub.2 NR.sup.1 R.sup.2) wherein R.sup.1 and R.sup.2, same or different, are hydrogen or loweralkyl wherein p is 0 or 1 and is the number of untreated hydroxyl groups and z is 1 or 2 and is the number of --OS(O.sub.2)NR.sup.1 R.sup.2 groups. Aryl is selected from phenyl, substituted phenyl, pyridinyl, naphthyl, quinolinyl, and the like. Phenyl substituents are selected from hydrogen, halo, hydroxy, phenyl, phenoxy, benzoyl, loweralkyl, loweralkoxy, carboxy, amino, loweralkylamino, diloweralkylamino, acetamido, cyano, nitro, loweralkoxycarboyl, aminosulfonyl, imidazolyl, triazolyl, and the like. Novel compounds not previously disclosed are also described.

  以下披露了一种使用含有化合物的药物组合物来治疗惊厥的方法：(HO).sub.p --A--[OSO.sub.2 NR.sup.1 R.sup.2 ].sub.z，其中A是芳基、芳基烷基或芳氧烷基基团，并在1个或多个碳原子上用磺酰胺基团(--OSO.sub.2 NR.sup.1 R.sup.2)取代，其中R.sup.1和R.sup.2，相同或不同，是氢或较低烷基，其中p为0或1，是未处理的羟基团的数量，z为1或2，是--OS(O.sub.2)NR.sup.1 R.sup.2基团的数量。芳基选自苯基、取代苯基、吡啶基、萘基、喹啉基等。苯基取代基选自氢、卤素、羟基、苯基、苯氧基、苯甲酰基、较低烷基、较低烷氧基、羧基、氨基、较低烷基氨基、二较低烷基氨基、乙酰胺基、氰基、硝基、较低烷氧羰基、氨基磺酰基、咪唑基、三唑基等。还描述了以前未披露的新化合物。
• Compounds having one or more aminosulfaonyloxy radicals useful as
  申请人：A. H. Robins Company, Incorporated

  公开号：US05194446A1

  公开（公告）日：1993-03-16

  Methods of treating chronic arthritis and osteoporosis which utilize both known and novel compounds which would fall under the general formula: (HO)p--A--[--OS(O).sub.2 NR.sup.1 R.sup.2 ].sub.z wherein A encompasses a wide range of values including but not limited to aryl, loweralkyl, cycloalkyl, and carbohydrates including sucrose and fructose; p is equal to the number of unreacted hydroxy groups contained on the molecule and may be zero; z is the number of --OS(O).sub.2 NR.sup.1 R.sup.2 groups and is always at least one; R.sup.1 and R.sup.2 are selected from hydrogen, loweralkyl, carboxy and the like; a novel process for preparing the compounds is provided wherein an appropriate sulfamic acid aryl ester is reacted with a hydroxy substituted A radical which may or may not contain thereon protected carboxyl, amino or hydroxy substituents, in an aprotic solvent containing a tertiary amine base. Pharmaceutical compositions for the treatment of chronic arthritis and osteoporosis are also provided.

  治疗慢性关节炎和骨质疏松症的方法利用已知和新颖的化合物，这些化合物可归入一般公式：(HO)p--A--[--OS(O).sub.2 NR.sup.1 R.sup.2 ].sub.z，其中A包括一系列值，包括但不限于芳基、较低烷基、环烷基和碳水化合物，包括蔗糖和果糖；p等于分子中未反应的羟基数，可以为零；z是--OS(O).sub.2 NR.sup.1 R.sup.2基团的数量，始终至少为一；R.sup.1和R.sup.2从氢、较低烷基、羧基等中选择；提供了一种制备这些化合物的新方法，其中适当的磺酸酯与含有保护羧基、氨基或羟基取代基的羟基取代的A基团在含有三级胺碱的无水溶剂中反应。还提供了用于治疗慢性关节炎和骨质疏松症的药物组合物。
• Copper(ii)-catalyzed C–O coupling of aryl bromides with aliphatic diols: synthesis of ethers, phenols, and benzo-fused cyclic ethers
  作者：Yajun Liu、Se Kyung Park、Yan Xiao、Junghyun Chae

  DOI：10.1039/c4ob00649f

  日期：——

  copper-catalyzed C–O cross-coupling reaction between aryl bromides and aliphatic diols has been developed employing a cheaper, more efficient, and easily removable copper(II) catalyst. A broad range of aryl bromides were coupled with aliphatic diols of different lengths using 5 mol% CuCl2 and 3 equivalents of K2CO3 in the absence of any other ligands or solvents to afford the corresponding hydroxyalkyl aryl ethers

  使用更便宜，更有效且易于去除的铜（II）催化剂，开发了一种高效的铜催化的芳基溴化物与脂肪族二醇之间的C-O交叉偶联反应。使用5 mol％的CuCl 2和3当量的K 2 CO 3将宽范围的芳基溴化物与不同长度的脂肪族二醇偶联在不存在任何其他配体或溶剂的情况下，以良好或优异的收率得到相应的羟烷基芳基醚。在这个新开发的方案中，脂族二醇具有多方面的功能，如偶联反应物，配体和溶剂。所得的羟烷基芳基醚进一步容易地转化成相应的苯酚，为从芳基溴化物得到的苯酚提供了一种有价值的替代方法。此外，已证明它们是用于更高级分子如苯并呋喃和苯并稠合的环醚的有用中间体。
• Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
  申请人：Biovitrum AB

  公开号：US06465467B1

  公开（公告）日：2002-10-15

  Compounds of the general formula (I): wherein the variables are as defined in the specification are useful for the prophylaxis or treatment of serotonin-related, especially 5-HT2 receptor-related, diseases in human beings or animals, particularly diseases related to the 5-HT2c receptor, especially diseases such as eating disorders, memory disorders, schizophrenia, mood disorders, anxiety disorders, pain, sexual dysfunctionions, and urinary disorders.

  通式（I）的化合物： 其中变量如规范中定义的那样，对于预防或治疗人类或动物中与血清素相关，特别是5-HT2受体相关的疾病是有用的，特别是与5-HT2c受体相关的疾病，尤其是与进食障碍、记忆障碍、精神分裂症、情绪障碍、焦虑障碍、疼痛、性功能障碍和尿液障碍等疾病相关的疾病。
• Selective formylation of alcohols in the presence of phenols with chloral
  作者：Ram N Ram、Nabin Kumar Meher

  DOI：10.1016/s0040-4020(02)00185-0

  日期：2002.4

  Primary and secondary alcohols were formylated selectively in the presence of phenols by stirring with chloral in acetone over anhydrous K2CO3 at ambient temperatures in high yields.

  在环境温度下，在无水K 2 CO 3上与丙酮中的乙二醛搅拌，在苯酚存在下，选择性地使伯醇和仲醇甲酰化，收率很高。